# ALHEMO
> **BLA761428** · Biologics License Application · Sponsor: NOVO NORDISK INC · Approved 2025-07-31
## Drug
- **FDA Application Number:** BLA761428
- **Application type:** Biologics License Application
- **Brand name:** ALHEMO
- **Generic name:** Concizumab
- **Active ingredients:** CONCIZUMAB
- **Dosage form:** SOLUTION
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** NOVO NORDISK INC
- **First approval:** 2025-07-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761428)
---
*MORVS · CC0 1.0*